Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia
Author:
Funder
National Institutes of Health
St Jude Children's Research Hospital
Publisher
Elsevier BV
Subject
Pediatrics, Perinatology and Child Health
Reference130 articles.
1. Childhood acute lymphoblastic leukemia: progress through collaboration;Pui;J Clin Oncol,2015
2. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000;Möricke;Blood,2016
3. Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from Children's Oncology Group study AALL0232;Larsen;J Clin Oncol,2016
4. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial;Place;Lancet Oncol,2015
5. Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial;Domenech;Haematologica,2014
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Global, regional, and national burdens of leukemia from 1990 to 2019: A systematic analysis of the global burden of disease in 2019 based on the APC model;Cancer Medicine;2024-09
2. Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis;Cancer Reports;2024-08
3. The ratio of SRSF1-IS1/IS2 mRNA is a marker of clinical prognosis in pediatric B-ALL and SRSF1 isoforms differentially regulate apoptosis and proliferation on leukemic cells;2024-04-22
4. Introduction to microbial genomics;Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications;2024
5. Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns;eClinicalMedicine;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3